The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

History of the Mitochondrial Free Radical Theory of Aging, 1954-1995
59. Matsuoka T, Goto Y, Nonaka I. “All-or-none” cytochrome c oxidase positivity in mitochondria
in chronic progressive external ophthalmoplegia: an ultrastructural-cytochemical study. Muscle
Nerve 1993; 16:206-209.
60. Ozawa T. Mechanism of somatic mitochondrial DNA mutations associated with age and
diseases. Biochim Biophys Acta 1995; 1271:177-189.
61. Lee CM, Lopez ME Weindruch R et al. Association of age-related mitochondrial abnormalities
with skeletal muscle fiber atrophy. Free Radic Biol Med 1998; 25:964-972.
62. a)Brierley EJ, Johnson MA, Lightowlers RN et al. Role of mitochondrial DNA mutations
in human aging: Implications for the central nervous system and muscle. Ann Neurol 1998;
43:217-223.
62. b)Khrapko K, Bodyak N, Thilly WG et al. Cell-by-cell scanning of whole mitochondrial
genomes in aged human heart reveals a significant fraction of myocytes with clonally
expanded deletions. Nucleic Acids Res 1999; 27:2434-2441.
62. c)Moslemi AR, Melberg A, Holme E et al. Clonal expansion of mitochondrial DNA with
multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol
1996; 40: 707-713.
63. Fawcett DW, Bloom W. A textbook of histology. 12th ed. New York: Chapman and Hall,
1994.
64. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain
reaction. Methods Enzymol 1987; 155:335-350.
65. Barnes WM. PCR amplification of up to 35-kb DNA with high fidelity and high yield
from lambda bacteriophage templates. Proc Natl Acad Sci USA 1994; 91:2216-2220.
66. Cheng S, Higuchi R, Stoneking M. Complete mitochondrial genome amplification. Nature
Genet 1994; 7:350-351.
67. Reynier P, Malthiery Y. Accumulation of deletions in MtDNA during tissue aging: analysis
by long PCR. Biochem Biophys Res Commun 1995; 217:59-67.
68. Desjardins P, Frost E, Morais R. Ethidium bromide-induced loss of mitochondrial DNA
from primary chicken embryo fibroblasts. Mol Cell Biol 1985; 5:1163-1169.
69. King MP, Attardi G. Human cells lacking mtDNA: Repopulation with exogenous
mitochondria by complementation. Science 1989; 246:500-503.
70. Chomyn A, Lai ST, Shakeley R et al. Platelet-mediated transformation of mtDNA-less
human cells: Analysis of phenotypic variability among clones from normal individuals and
complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged
red fibers. Am J Hum Genet 1994; 54:966-974.
71. Yoneda M, Chomyn A, Martinuzzi A et al. Marked replicative advantage of human mtDNA
carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci
USA 1992; 89:11164-11168.
72. Dunbar DR, Moonie PA, Jacobs HT et al. Different cellular backgrounds confer a marked
advantage to either mutant or wild-type mitochondrial genomes. Proc Natl Acad Sci USA
1995; 92: 6562-6566.
73. King MP. Transmitochondrial cells in the study of mitochondrial disease. Molec Genet
Metab 1998; 63:43.
74. Peterson ER, Crain SM. Regeneration and innervation in cultures of adult mammalian
skeletal muscle coupled with fetal rodent spinal cord. Exp Neurol 1972; 36:136-159.
75. Arnheim N, Cortopassi G. Deleterious mitochondrial DNA mutations accumulate in aging
human tissues. Mutat Res 1992; 275:157-167.
76. Münscher C, Müller-Höcker J, Kadenbach B. Human aging is associated with various point
mutations in tRNA genes of mitochondrial DNA. Biol Chem Hoppe Seyler 1993;
374:1099-1104.
77. Kadenbach B, Münscher C, Frank V et al. Human aging is associated with stochastic somatic
mutations of mitochondrial DNA. Mutat Res 1995; 338:161-172.
78. Pallotti F, Chen X, Bonilla E et al. Evidence that specific mtDNA point mutations may not
accumulate in skeletal muscle during normal human aging. Am J Hum Genet 1996;
59:591-602.
83